Elhaieg A, Farag A, Mandour A, Hirose M, Elfadadny A, Tanaka R
Biology (Basel). 2025; 14(2).
PMID: 40001895
PMC: 11851954.
DOI: 10.3390/biology14020127.
Kudelka M, Lavin Y, Sun S, Fuchs E
Genes Dev. 2024; 39(1-2):18-35.
PMID: 39455281
PMC: 11789493.
DOI: 10.1101/gad.351990.124.
Jang J, Lee B, Huang M, Seo C, Choi J, Shin Y
Mol Oncol. 2024; 18(8):1923-1939.
PMID: 38511232
PMC: 11306519.
DOI: 10.1002/1878-0261.13633.
Zohud O, Lone I, Nashef A, Iraqi F
Animal Model Exp Med. 2023; 6(6):537-558.
PMID: 38129938
PMC: 10757216.
DOI: 10.1002/ame2.12367.
Jagadeeshan S, Novoplansky O, Cohen O, Kurth I, Hess J, Rosenberg A
Biochim Biophys Acta Rev Cancer. 2023; 1878(6):188963.
PMID: 37619805
PMC: 11815531.
DOI: 10.1016/j.bbcan.2023.188963.
Genetically engineered mouse models of head and neck cancers.
Tasoulas J, Srivastava S, Xu X, Tarasova V, Maniakas A, Karreth F
Oncogene. 2023; 42(35):2593-2609.
PMID: 37474617
PMC: 10457205.
DOI: 10.1038/s41388-023-02783-7.
Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer.
Chiu W, Ou D, Tan C
Int J Mol Sci. 2022; 23(16).
PMID: 36012461
PMC: 9409124.
DOI: 10.3390/ijms23169195.
Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.
Shi Y, Xie T, Wang B, Wang R, Cai Y, Yuan B
Commun Biol. 2022; 5(1):757.
PMID: 35902768
PMC: 9334280.
DOI: 10.1038/s42003-022-03675-4.
Proliferation and Apoptosis Pathways and Factors in Oral Squamous Cell Carcinoma.
He S, Chakraborty R, Ranganathan S
Int J Mol Sci. 2022; 23(3).
PMID: 35163485
PMC: 8836072.
DOI: 10.3390/ijms23031562.
Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition.
Alhousami T, Diny M, Ali F, Shin J, Kumar G, Kumar V
Mol Cancer Res. 2022; 20(5):712-721.
PMID: 35105672
PMC: 9081163.
DOI: 10.1158/1541-7786.MCR-21-0310.
Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention.
Dey S, Singh A, Singh A, Rawat K, Banerjee J, Agnihotri V
Med Oncol. 2022; 39(3):30.
PMID: 35059897
DOI: 10.1007/s12032-021-01633-4.
Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?.
Theile D, Wizgall P
Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(8):1621-1632.
PMID: 34236499
PMC: 8298356.
DOI: 10.1007/s00210-021-02112-3.
Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.
Shi Y, Xie T, Leach D, Wang B, Young S, Osman A
Cancer Prev Res (Phila). 2021; 14(8):767-778.
PMID: 34021022
PMC: 8338806.
DOI: 10.1158/1940-6207.CAPR-20-0607.
A smooth muscle-derived, Braf-driven mouse model of gastrointestinal stromal tumor (GIST): evidence for an alternative GIST cell-of-origin.
Kondo J, Huh W, Franklin J, Heinrich M, Rubin B, Coffey R
J Pathol. 2020; 252(4):441-450.
PMID: 32944951
PMC: 7802691.
DOI: 10.1002/path.5552.
Identification of SPRR3 as a novel diagnostic/prognostic biomarker for oral squamous cell carcinoma via RNA sequencing and bioinformatic analyses.
Yu L, Yang Z, Liu Y, Liu F, Shang W, Shao W
PeerJ. 2020; 8:e9393.
PMID: 32596058
PMC: 7305774.
DOI: 10.7717/peerj.9393.
[Development of precancerous lesions of oral mucous membrane diseases and oral cancer animal models].
Cheng J, Bai H, Chang Z, Li J, Chen Q
Hua Xi Kou Qiang Yi Xue Za Zhi. 2020; 38(2):198-204.
PMID: 32314895
PMC: 7184277.
DOI: 10.7518/hxkq.2020.02.015.
New insights into the functions of Cox-2 in skin and esophageal malignancies.
Moon H, White A, Borowsky A
Exp Mol Med. 2020; 52(4):538-547.
PMID: 32235869
PMC: 7210257.
DOI: 10.1038/s12276-020-0412-2.
Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma.
Li Q, Dong H, Yang G, Song Y, Mou Y, Ni Y
Front Oncol. 2020; 10:212.
PMID: 32158692
PMC: 7052016.
DOI: 10.3389/fonc.2020.00212.
MiR-181d functions as a potential tumor suppressor in oral squamous cell carcinoma by targeting K-ras.
Shi Y, Li Y, Wu W, Xu B, Ju J
Int J Clin Exp Pathol. 2020; 10(7):7847-7855.
PMID: 31966632
PMC: 6965231.
Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck.
Sasaki E, Masago K, Fujita S, Hanai N, Yatabe Y
J Pathol Clin Res. 2020; 6(2):154-159.
PMID: 31960612
PMC: 7164371.
DOI: 10.1002/cjp2.157.